<p>Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China</p>-Reference-Cited by-同舟云学术

Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China

Published:2020-10 Issue: Volume:Volume 13 Page:3679-3687
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Zhang Yuou,Liu Xuan,Yang Linghe,Zhang Guifang,Gu Zhaoru^ORCID,Chen Zhongdan,Sun Jing^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference47 articles.

1. World Health Organization. Rapid Communication: Key Changes to Treatment of Multidrug‑and Rifampicin‑resistant Tuberculosis (MDR/RR‑TB). Geneva: World Health Organization; 2018.

2. World Health Organization. The Use of Bedaquiline in the Treatment of Multidrug‑resistant Tuberculosis: Interim Policy Guidance. Geneva: World Health Organization; 2013.

3. Management of patients with multidrug-resistant tuberculosis

4. World Health Organization. Global Tuberculosis Report 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. Accessed 8 June 2020.

5. Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying enablers and barriers to the control of multidrug-resistant tuberculosis in Abia State, Nigeria: A qualitative study;SSM - Health Systems;2024-12

2. Thermophage triumph: Harnessing archaeal plasmids in the fight against tuberculosis;Gene Reports;2024-09

3. Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study;Frontiers in Public Health;2023-06-20

4. Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study;BMC Infectious Diseases;2022-11-22

5. Impact of financial support on treatment outcomes of multidrug-resistant tuberculosis: a population-based, retrospective cohort study in China;2022-11-08